Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM
The inventors of a cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, SurVaxM — a multimillion-dollar licensing deal that will help enable large, randomized clinical...
20-Nov-2019 10:15 AM EST Add to Favorites
Roswell Park's Dr. Clare Twist led an effort to develop and validate a new treatment algorithm for infants and children with neuroblastoma. In a new study in the Journal of Clinical Oncology, the team reports that many patients can safely receive...
2-Oct-2019 9:50 AM EDT Add to Favorites
In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival...
18-Sep-2019 11:05 AM EDT Add to Favorites
A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a DoD grant that will fund a clinical trial in patients with brain-metastatic breast cancer.
18-Sep-2019 10:40 AM EDT Add to Favorites
Roswell Park researchers have received recent grant awards totaling more than $15.4 million. These competitive awards include the first National Institutes of Health funding to study a new electronic tobacco device and a state grant supporting...
13-Aug-2019 4:55 PM EDT Add to Favorites
Roswell Park Researchers Identify Immune Biomarker of Response in Patients With Advanced Liver Cancer
Roswell Park researchers have uncovered a biomarker that may help explain why some patients respond better than others to sorafenib, a chemotherapy commonly prescribed for patients with advanced liver cancer.
13-Aug-2019 4:45 PM EDT Add to Favorites
Researchers from Roswell Park have developed a new bioinformatics-based approach for monitoring key changes in cancer cells — a data-driven method that might help to enhance and personalize cancer treatment.
1-Aug-2019 2:05 PM EDT Add to Favorites
A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration (FDA) for patients with an aggressive form of non-Hodgkin lymphoma.
19-Jun-2019 6:05 PM EDT Add to Favorites
see all news
25-Jan-2017 10:05 AM EST
Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch
22-Sep-2016 3:05 PM EDT
Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk
27-Oct-2015 5:05 PM EDT
Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT